Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

ADC Therapeutics (ADCT) Amortizatization of Intangibles: 2021-2023

Historic Amortizatization of Intangibles for ADC Therapeutics (ADCT) over the last 2 years, with Dec 2023 value amounting to $7.2 million.

  • ADC Therapeutics' Amortizatization of Intangibles fell 41.35% to $7.2 million in Q4 2023 from the same period last year, while for Dec 2023 it was $19.2 million, marking a year-over-year increase of 57.41%. This contributed to the annual value of $28.2 million for FY2024, which is 46.95% up from last year.
  • According to the latest figures from Q4 2023, ADC Therapeutics' Amortizatization of Intangibles is $7.2 million, which was up 6.73% from $6.7 million recorded in Q3 2023.
  • ADC Therapeutics' Amortizatization of Intangibles' 5-year high stood at $12.2 million during Q4 2022, with a 5-year trough of -$37 in Q2 2022.
  • Its 3-year average for Amortizatization of Intangibles is $3.2 million, with a median of $495,048 in 2021.
  • Examining YoY changes over the last 5 years, ADC Therapeutics' Amortizatization of Intangibles showed a top increase of 20,318,281.82% in 2023 and a maximum decrease of 41.35% in 2023.
  • Over the past 3 years, ADC Therapeutics' Amortizatization of Intangibles (Quarterly) stood at $129,096 in 2021, then soared by 9,351.96% to $12.2 million in 2022, then plummeted by 41.35% to $7.2 million in 2023.
  • Its Amortizatization of Intangibles stands at $7.2 million for Q4 2023, versus $6.7 million for Q3 2023 and $4.5 million for Q2 2023.